Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2020 Oct 28;20:522. doi: 10.1186/s12935-020-01610-3

Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade

Seyed Mohammad Miri 1, Mir Saeed Ebrahimzadeh 2, Elahe Abdolalipour 1, Mahsa Yazdi 2, Hassan Hosseini Ravandi 3, Amir Ghaemi 1,
PMCID: PMC7594438  PMID: 33132759

Correction to: Cancer Cell Int (2020) 20:380 10.1186/s12935-020-01476-5

Following publication of the original article [1], we were notified the Department of Virology, Pasteur Institute of Iran should have been mentioned as the only affiliation for the first, third and last author. The revised affiliation is reflected in this correction article.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Miri SM, Ebrahimzadeh MS, Abdolalipour E, Yazdi M, Ravandi HH, Ghaemi A. Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade. Cancer Cell Int. 2020;20:380. doi: 10.1186/s12935-020-01476-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES